Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000638 |
Amiodarone |
Amiodarone results in increased expression of FOXP3 mRNA | increases expression | 19774075
|
D001374 |
Azacitidine |
[Azacitidine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein | affects cotreatment|increases expression | 18493985
|
D001374 |
Azacitidine |
[Azacitidine results in decreased methylation of FOXP3 gene] which results in increased expression of FOXP3 protein | decreases methylation|increases expression | 18493985
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of FOXP3 mRNA | decreases expression | 15591121
|
C014347 |
decitabine |
[decitabine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein | affects cotreatment|increases expression | 18567616
|
C014347 |
decitabine |
[[decitabine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein] which results in increased expression of IFNG protein | affects cotreatment|increases expression | 18567616
|
C014347 |
decitabine |
[[decitabine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein] which results in increased expression of IL17A protein | affects cotreatment|increases expression | 18567616
|
C014347 |
decitabine |
[[decitabine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein] which results in increased expression of IL2 protein | affects cotreatment|increases expression | 18567616
|
C014347 |
decitabine |
[[decitabine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein] which results in increased expression of TNF protein | affects cotreatment|increases expression | 18567616
|
C014347 |
decitabine |
[decitabine results in decreased methylation of FOXP3 gene] which results in increased expression of FOXP3 mRNA | decreases methylation|increases expression | 18567616
|
C014347 |
decitabine |
[decitabine results in decreased methylation of FOXP3 gene] which results in increased expression of FOXP3 protein | decreases methylation|increases expression | 18567616
|
C014347 |
decitabine |
[decitabine co-treated with TGFB1 protein] promotes the reaction [KLF10 protein binds to FOXP3 promoter] | affects binding|affects cotreatment|increases reaction | 19109157
|
C014347 |
decitabine |
decitabine results in decreased methylation of FOXP3 promoter | decreases methylation | 19109157
|
C014347 |
decitabine |
decitabine results in increased expression of FOXP3 mRNA | increases expression | 19109157
|
C014347 |
decitabine |
decitabine results in increased expression of FOXP3 protein | increases expression | 19545742 19109157
|
C014347 |
decitabine |
TGFB1 protein promotes the reaction [decitabine results in increased expression of FOXP3 protein] | increases expression|increases reaction | 19109157
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FOXP3 mRNA | affects cotreatment|increases expression | 17942748
|
C070081 |
fulvestrant |
fulvestrant results in increased expression of FOXP3 mRNA | increases expression | 20145137
|
C070081 |
fulvestrant |
TGFB1 protein promotes the reaction [fulvestrant results in increased expression of FOXP3 mRNA] | increases expression|increases reaction | 20145137
|
D006830 |
Hydralazine |
Hydralazine results in increased expression of FOXP3 protein | increases expression | 19109157
|
D011342 |
Procainamide |
Procainamide results in increased expression of FOXP3 protein | increases expression | 19109157
|
C503639 |
RG108 |
RG108 results in increased expression of FOXP3 protein | increases expression | 19109157
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of FOXP3 mRNA | increases expression | 20145137
|
D013629 |
Tamoxifen |
TGFB1 protein promotes the reaction [Tamoxifen results in increased expression of FOXP3 mRNA] | increases expression|increases reaction | 20145137
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FOXP3 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of FOXP3 protein | decreases expression | 18684927
|
C012589 |
trichostatin A |
trichostatin A results in increased expression of FOXP3 protein | increases expression | 19545742
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.72 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.90 | 18218290 18057881 20041841 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
10.64 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.64 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.98 | 19698954 18651412 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.97 | 11514358 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
9.41 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.41 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 17570480 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.39 | 15136595 17388661 16978400 18234424 18323546 11325840 12006526 15093573 17020986 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.39 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.39 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.39 | 19011961 17242785 19084267 16202921 20135344 17440819 11161223 18425577 19115204 19066611 15668708 16873071 19142967 19103187 18855134 21152245 18629630 19289846 18351453 19244106 19155303 19059307 19189210 16273361 19221464 18821012 20544844 18997820 15565566 18984771 19288272 16818667 19189212 20390343 17893378 19410462 18815881 21138602 17261762 19200415 20005174 19487384 20859285 20065188 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.39 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.64 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.34 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.34 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.04 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.58 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.62 | 19215824 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.72 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 18670907 16120746 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.92 | 19225199 15710769 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.24 | 18974383 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.95 | 16919318 17681005 17333356 16105132 15861022 11677210 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 8697196 15340226 15668235 16354765 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.35 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.92 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.92 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.16 | 15643279 18483878 18433785 11948286 15276878 18710439 12388444 16651033 18372110 12161096 10498854 17979934 12913760 10700343 16614059 18295254 16413132 17010015 18093676 16989017 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.50 | 19031437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.16 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
marker/mechanism |
|
| |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.25 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.57 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
3.95 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.95 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.37 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.37 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
14.62 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
14.62 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.11 | 16202921 20544844 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.35 | 11006010 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
13.80 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.80 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
13.80 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.30 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.68 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.34 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
3.90 | 18801729 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.67 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.17 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.56 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 11294989 10048152 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.43 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.71 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
9.01 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.01 | 12621046 15340226 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.88 | 16135485 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.98 | 9751232 8137927 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.76 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.65 | 17991464 18020914 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.51 | 16076520 |
OMIM:304790 |
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED |
marker/mechanism |
|
| |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
16.73 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
16.73 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
16.73 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
16.73 | 11514358 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.07 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.07 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.13 | 18625569 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
11.02 | 19148494 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
11.02 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
11.02 | 18980019 19235587 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.54 | 18172266 17802794 17658394 17008537 17296974 18587576 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.17 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
10.27 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
10.27 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
6.49 | 18720364 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.49 | 18704418 17679729 18206229 18460780 19387464 19010910 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
6.49 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.64 | 18055864 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.31 | 19299654 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.12 | 10052129 11830472 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
8.18 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
8.18 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.31 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.52 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.52 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.17 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.66 | 11989578 15350150 17391786 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.44 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.65 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
3.56 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.56 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.56 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.12 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
8.12 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.71 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.26 | 11911406 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.91 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.69 | 11731420 16827153 14580682 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.72 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.34 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.34 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
5.34 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.34 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.94 | 16388313 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.26 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
12.81 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
12.81 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
12.81 | 18172295 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
5.08 | 17974566 12754197 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
8.02 | 17611569 19805378 17596541 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
8.02 | 16882708 19010910 18608210 19157545 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.58 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.55 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.62 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.62 | 19116145 19470736 17925555 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.17 | 19200415 19189210 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.69 | 8761367 16115947 15176712 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.04 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.44 | 8291058 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.86 | 16517039 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.37 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
5.37 | 19331143 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.71 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
9.07 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
9.07 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
9.07 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.86 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11222880 11118676 11399792 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
12.90 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
12.90 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.17 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.17 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.17 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.17 | 19789329 18798265 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
6.10 | 12490602 12832656 11597910 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
6.10 | 16636934 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.52 | 19155313 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.94 | 16636934 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.24 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.15 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.15 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.67 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.19 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.42 | 18087811 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.21 | 12837982 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.42 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.32 | 19225199 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
12.64 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
12.64 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.41 | 17967635 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
5.00 | 19584973 18020914 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.34 | 17467628 11989578 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
8.69 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.69 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.69 | 8653321 16712894 17572228 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.09 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |